COMMUNIQUÉS West-GlobeNewswire

NEOVACS : SUSPENSION DE COURS

28/06/2018 - 18:01

COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE SUSPENSION DE COURS Paris et Boston, le 28 juin 2018 - 18 : 00 pm CEST - Néovacs (Euronext Growth Paris : ALNEV), a demandé à Euronext Paris la [...]

Novacap completes the acquisition of PCI Synthesis and expands its pharmaceutical offerings in the U.S.

28/06/2018 - 18:01

LYON, France and NEWBURYPORT, Mass., June 28, 2018 (GLOBE NEWSWIRE) -- Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, announced today that it has completed the acquisition of PCI [...]

electroCore, Inc. Announces Exercise of Underwriters' Option to Purchase Additional Shares in Initial Public Offering

28/06/2018 - 17:45

BASKING RIDGE, N.J., June 28, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq:ECOR) today announced that the underwriters of its previously announced initial public offering of common stock have [...]

Medtronic Launches the MiniMed(TM) 670G System Performance Guarantee for Payers and Employers

28/06/2018 - 17:37

DUBLIN- June 28, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the launch of the MiniMed(TM) 670G Performance Guarantee Program - an outcomes-based offering for payers and [...]

Tivity Health to Issue Second Quarter 2018 Financial Results After Market Close on August 2

28/06/2018 - 17:00

Company to Host Conference Call and Live Webcast Nashville, Tenn., June 28, 2018 (GLOBE NEWSWIRE) -- Tivity Health, Inc. (NASDAQ: TVTY) today announced that its financial results for the second quarter ending June 30, [...]

Meridian Bioscience, Inc. Expects to Report Third Quarter Fiscal Year 2018 Operating Results on Tuesday, July 31, 2018

28/06/2018 - 17:00

CINCINNATI, June 28, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading life science company, expects to release its third quarter fiscal 2018 operating results before the NASDAQ market opens on [...]

MolMed and AbCheck sign a three-year Master Agreement for the development of new CARs targeting novel tumor antigens

28/06/2018 - 16:34

The collaboration with AbCheck will allow MolMed to enlarge its proprietary CAR pipeline for both liquid and solid malignancies Milan (Italy) and Plzen (Czech Republic), June 28 th 2018 - MolMed S.p.A. (MLMD.MI), a [...]

Abattis Enters Into Definitive Agreement to Launch New Cannabis Lab in Ontario

28/06/2018 - 16:29

VANCOUVER, British Columbia, June 28, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “ Company ” or “ Abattis ”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that it has entered into a definitive investment [...]

CORRECTION - Hydropothecary déclare les résultats du troisième trimestre de l’exercice 2018

28/06/2018 - 16:20

GATINEAU, Québec, 28 juin 2018 (GLOBE NEWSWIRE) -- Veuillez noter qu'une correction a été apportée au communiqué de presse diffusé ce 28 juin 2018, à 6 h 30 HAE. Dans le paragraphe sous " À propos de Hexo ", il aurait [...]

Theratechnologies to Announce Financial Results for Second Quarter 2018

28/06/2018 - 15:41

MONTREAL, June 28, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX:TH) ( Theratechnologies ) announced today that it will issue its financial results for the first quarter ended May 31, 2018, on Thursday, July 5, [...]

Theratechnologies annoncera ses résultats du deuxième trimestre de 2018

28/06/2018 - 15:41

MONTRÉAL, 28 juin 2018 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies ») (TSX:TH) a annoncé aujourd’hui qu’elle dévoilerait ses résultats financiers jeudi le 5 juillet 2018 pour l’exercice financier [...]

Cue Biopharma Strengthens Board of Directors with Addition of Fred Driscoll to Chair Audit Committee

28/06/2018 - 15:15

Driscoll Brings More Than 20 Years of Experience in Financial Management of Life Sciences Companies CAMBRIDGE, Mass., June 28, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc., (NASDAQ:CUE) a next-generation immunotherapy [...]

Cantabio Announces Publication of Study on Druggability of the Tau protein in ACS Chemical Neuroscience

28/06/2018 - 15:02

Structural biology based evidence shows that native monomeric Tau can be a viable target for drug-like small molecules, despite its heterogeneous structure SUNNYVALE, Calif., June 28, 2018 (GLOBE NEWSWIRE) -- Cantabio [...]

RedHill Biopharma Announces U.S. Co-Promotion Agreement with Napo Pharmaceuticals for HIV/AIDS Anti-Diarrheal Drug Mytesi®

28/06/2018 - 15:00

RedHill has been granted the exclusive right to co-promote Mytesi ® (crofelemer 125 mg delayed-release tablets) in the U.S. to certain gastroenterologists and primary care physicians for the approved indication in [...]

Cytori Reports Improved Skin Healing in Pivotal Burn Preclinical Study

28/06/2018 - 15:00

BARDA Funded Study Published in the Journal “Burns” SAN DIEGO, June 28, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq:CYTX) announced today the publication of preclinical data from a study using intravenous [...]

Konica Minolta Launches Portable Ultrasound with One-touch Image Optimization for Improved Workflow and Diagnostic Efficiency

28/06/2018 - 15:00

WAYNE, N.J., June 28, 2018 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc., announces the introduction of the SONIMAGE® MX1 portable ultrasound system, optimized for musculoskeletal (MSK) and orthopedic [...]

BlissCo's International Cannabis Ecosystem Taking Shape -- CFN Media

28/06/2018 - 15:00

SEATTLE, June 28, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering [...]

AXIM® Biotechnologies to Present at 28th Annual International Cannabinoid Research Society Symposium in The Netherlands

28/06/2018 - 15:00

NEW YORK, June 28, 2018 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (AXIM ® Biotech ) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the company will be attending as a [...]

XORTX Reports on Annual Special Meeting and Provides Corporate Update

28/06/2018 - 14:59

CALGARY, Alberta, June 28, 2018 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“ XORTX ” or the “ Company ”) (CSE:XRX) (OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat [...]